704 related articles for article (PubMed ID: 26386985)
21. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia.
Hamauchi S; Furuse J; Takano T; Munemoto Y; Furuya K; Baba H; Takeuchi M; Choda Y; Higashiguchi T; Naito T; Muro K; Takayama K; Oyama S; Takiguchi T; Komura N; Tamura K
Cancer; 2019 Dec; 125(23):4294-4302. PubMed ID: 31415709
[TBL] [Abstract][Full Text] [Related]
22. Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model.
Northrup R; Kuroda K; Duus EM; Barnes SR; Cheatham L; Wiley T; Pietra C
Support Care Cancer; 2013 Sep; 21(9):2409-15. PubMed ID: 23579947
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacological profile and clinical efficacy of anamorelin HCl (ADLUMIZ
Nakanishi Y; Higuchi J; Honda N; Komura N
Nihon Yakurigaku Zasshi; 2021; 156(6):370-381. PubMed ID: 34719572
[TBL] [Abstract][Full Text] [Related]
24. [Development of Therapy for Cancer Cachexia in Pancreatic Cancer].
Mitsunaga S
Gan To Kagaku Ryoho; 2022 Jul; 49(7):728-731. PubMed ID: 35851339
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacological therapy of cancer anorexia-cachexia].
Cardona D
Nutr Hosp; 2006 May; 21 Suppl 3():17-26. PubMed ID: 16768027
[TBL] [Abstract][Full Text] [Related]
26. Ghrelin as a Promising Therapeutic Option for Cancer Cachexia.
Khatib MN; Gaidhane A; Gaidhane S; Quazi ZS
Cell Physiol Biochem; 2018; 48(5):2172-2188. PubMed ID: 30110683
[TBL] [Abstract][Full Text] [Related]
27. Current pharmacotherapy options for cancer anorexia and cachexia.
Macciò A; Madeddu C; Mantovani G
Expert Opin Pharmacother; 2012 Dec; 13(17):2453-72. PubMed ID: 23072481
[TBL] [Abstract][Full Text] [Related]
28. Cancer anorexia-cachexia syndrome: current issues in research and management.
Inui A
CA Cancer J Clin; 2002; 52(2):72-91. PubMed ID: 11929007
[TBL] [Abstract][Full Text] [Related]
29. Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice.
Yoshimura M; Shiomi Y; Ohira Y; Takei M; Tanaka T
Eur J Pharmacol; 2017 Sep; 811():30-37. PubMed ID: 28529141
[TBL] [Abstract][Full Text] [Related]
30. Cytokines and cancer anorexia cachexia syndrome.
Bennani-Baiti N; Davis MP
Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
[TBL] [Abstract][Full Text] [Related]
31. [Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].
Inui A
Rinsho Byori; 2006 Oct; 54(10):1044-51. PubMed ID: 17133993
[TBL] [Abstract][Full Text] [Related]
32. Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia.
Wang W; Andersson M; Iresjö BM; Lönnroth C; Lundholm K
Int J Oncol; 2006 Jun; 28(6):1393-400. PubMed ID: 16685441
[TBL] [Abstract][Full Text] [Related]
33. Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.
Fujitsuka N; Asakawa A; Uezono Y; Minami K; Yamaguchi T; Niijima A; Yada T; Maejima Y; Sedbazar U; Sakai T; Hattori T; Kase Y; Inui A
Transl Psychiatry; 2011 Jul; 1(7):e23. PubMed ID: 22832525
[TBL] [Abstract][Full Text] [Related]
34. Clinical results in cachexia therapeutics.
Crawford J
Curr Opin Clin Nutr Metab Care; 2016 May; 19(3):199-204. PubMed ID: 26974316
[TBL] [Abstract][Full Text] [Related]
35. Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.
Takayama K; Katakami N; Yokoyama T; Atagi S; Yoshimori K; Kagamu H; Saito H; Takiguchi Y; Aoe K; Koyama A; Komura N; Eguchi K
Support Care Cancer; 2016 Aug; 24(8):3495-505. PubMed ID: 27005463
[TBL] [Abstract][Full Text] [Related]
36. The role of ghrelin in anorexia-cachexia syndromes.
Guillory B; Splenser A; Garcia J
Vitam Horm; 2013; 92():61-106. PubMed ID: 23601421
[TBL] [Abstract][Full Text] [Related]
37. Anorexia and cachexia in advanced cancer patients.
Vigano A; Watanabe S; Bruera E
Cancer Surv; 1994; 21():99-115. PubMed ID: 8565002
[TBL] [Abstract][Full Text] [Related]
38. The Latest Treatments for Cancer Cachexia: An Overview.
Watanabe H; Oshima T
Anticancer Res; 2023 Feb; 43(2):511-521. PubMed ID: 36697073
[TBL] [Abstract][Full Text] [Related]
39. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
[TBL] [Abstract][Full Text] [Related]
40. Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis.
Nishie K; Yamamoto S; Nagata C; Koizumi T; Hanaoka M
Lung Cancer; 2017 Oct; 112():25-34. PubMed ID: 29191597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
